Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Nanotechnology Drug Delivery Market, by Formulation
1.4.2 North America Nanotechnology Drug Delivery Market, by Application
1.4.3 North America Nanotechnology Drug Delivery Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Nanotechnology Drug Delivery Market, by Formulation
4.1 North America Polymer-Based Nanomedicine Market, by Country
4.2 North America Lipid-Based Nanomedicine Market, by Country
4.3 North America Nanocrystals Market, by Country
4.4 North America Others Market, by Country
Chapter 5. North America Nanotechnology Drug Delivery Market, by Application
5.1 North America Oncology & Hematology Market, by Country
5.2 North America Infectious Diseases Market, by Country
5.3 North America Orthopedics Market, by Country
5.4 North America Neurology Market, by Country
5.5 North America Immunology Market, by Country
5.6 North America Urology Market, by Country
5.7 North America Others Market, by Country
Chapter 6. North America Nanotechnology Drug Delivery Market, by Country
6.1 US Nanotechnology Drug Delivery Market
6.1.1 US Nanotechnology Drug Delivery Market, by Formulation
6.1.2 US Nanotechnology Drug Delivery Market, by Application
6.2 Canada Nanotechnology Drug Delivery Market
6.2.1 Canada Nanotechnology Drug Delivery Market, by Formulation
6.2.2 Canada Nanotechnology Drug Delivery Market, by Application
6.3 Mexico Nanotechnology Drug Delivery Market
6.3.1 Mexico Nanotechnology Drug Delivery Market, by Formulation
6.3.2 Mexico Nanotechnology Drug Delivery Market, by Application
6.4 Rest of North America Nanotechnology Drug Delivery Market
6.4.1 Rest of North America Nanotechnology Drug Delivery Market, by Formulation
6.4.2 Rest of North America Nanotechnology Drug Delivery Market, by Application
Chapter 7. Company Profiles
7.1 AbbVie, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.1.6 SWOT Analysis
7.2 Pfizer, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional & Segmental Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.6 SWOT Analysis
7.3 Johnson & Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 SWOT Analysis
7.4 Novartis AG
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Bristol-Myers Squibb Company
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.6 SWOT Analysis
7.6 AstraZeneca PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Amgen, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Merck KGaA
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.8.6 SWOT Analysis
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 SWOT Analysis
7.10. Sanofi S.A.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis
Unique Offerings 